Table 3.
Results of multivariate analysis of 90 patients with breast cancer.
| B | SE | Wald | P-value | RR | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||||
| Age | −0.218 | 0.496 | 0.194 | .660 | 0.804 | 0.304 | 2.124 |
| Pathological grade | 1.458 | 0.564 | 6.689 | .010 | 4.299 | 1.424 | 12.980 |
| Tumor size | 2.199 | 0.487 | 20.365 | .000 | 9.012 | 3.468 | 23.417 |
| Lymph node metastasis | 1.531 | 0.633 | 5.851 | .016 | 4.621 | 1.337 | 15.969 |
| Pathological TNM staging | 1.217 | 0.505 | 5.805 | .016 | 3.376 | 1.255 | 9.082 |
| GSDMD-N | −2.116 | 0.750 | 7.949 | .005 | 0.121 | 0.028 | 0.525 |
| NLRP3 | −3.180 | 1.030 | 9.537 | .002 | 0.042 | 0.006 | 0.313 |
CI = confidence interval, GSDMD-N = gasdermin D N-terminal, NLRP3 = nucleotide-binding oligomerization domain-like receptor protein 3, RR = relative risk, SE = standard error.